Alex Goldberg

NASDAQ Decliners Watch List: Amazon.com Inc. (NASDAQ:AMZN) and Celgene Corporation (NASDAQ:CELG) Added to Equity Profile Report's NASDAQ Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/12/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Amazon.com Inc. (NASDAQ:AMZN) and Celgene Corporation (NASDAQ:CELG).

Amazon.com Inc. (NASDAQ:AMZN) a company that operates as an online retailer in North America and internationally closed down in its previous session (-1.44%) on 2,450,096 shares traded after Amazon Expanded Grocery-Delivery Service to San Francisco. Amazon.com Inc. (NASDAQ:AMZN) is currently down (-4.26%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Amazon.com Inc. (NASDAQ:AMZN)

Celgene Corporation (NASDAQ:CELG) a company that discovers, develops, and commercializes therapies for cancer and immune-inflammatory related diseases in the United States and Europe closed down in its previous session (-2.76%) on 3,075,933 shares traded after Celgene presented studies evaluating REVLIMID. Celgene Corporation (NASDAQ:CELG) is currently down (-4.65%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Celgene Corporation (NASDAQ:CELG)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com